Clinical Assessment of Axillary Lymph Nodes and Tumor Size in Breast Cancer Compared with Histopathological Examination: a Population-based Analysis of 2,537 Women

Overview

Journal World J Surg

Publisher Wiley

Specialty General Surgery

Date 2012 Sep 15

PMID 22976793

Citations 15

Authors

Shabaz Majid

Ingrid Tengrup

Jonas Manjer

Affiliations

Soon will be listed here.

Abstract

Background: The clinical assessment of axillary lymph nodes status and tumor size is important for the management of patients with breast cancer. The first goal of this study was to determine the accuracy of axillary lymph node status in relation to the presence of metastases as revealed by histopathological examination. The second goal was to compare the tumor size as assessed by physical examination, with the size obtained by histopathological examination.

Methods: This study was based on a consecutive series of 2,537 patients diagnosed with breast cancer in Malmö, Sweden, between 1987 and 2002. These patients had available information in the South Swedish Breast Cancer Group registry, corresponding to 97 %. The axillary lymph nodes status was compared with the results of the histopathological examination for the presence of metastases. Tumor size by physical examination was compared with the tumor size after histopathological examination.

Results: There were 674 women with axillary lymph nodes metastases according to histological examination; only 206 of these cases had palpable lymph nodes at clinical examination. The sensitivity was 30 % and the specificity 93 %. There were 812 tumors measured to be larger than 20 mm according to histopathological examination, but only 665 of these tumors were considered larger than 20 mm by clinical examination. This corresponded to a sensitivity of 81 % and a specificity of 80 %.

Conclusions: We conclude that the possibility of axillary metastases estimated by clinical examination is subjected to a large proportion of false-positive and false-negative results. Similarly, tumor size estimated by clinical examination is subject to under- and overestimation in comparison to histopathological examination.

Citing Articles

How to Optimize Deimplementation of Sentinel Lymph Node Biopsy?.

Dragvoll I, Bofin A, Soiland H, Engstrom M Breast J. 2025; 2024:7623194.

PMID: 39742356 PMC: 11142862. DOI: 10.1155/2024/7623194.

Risk factor analysis and clinicopathological characteristics of female dogs with mammary tumours from a single-center retrospective study in Poland.

Dolka I, Czopowicz M, Stopka D, Wojtkowska A, Kaszak I, Sapierzynski R Sci Rep. 2024; 14(1):5569.

PMID: 38448646 PMC: 10917774. DOI: 10.1038/s41598-024-56194-z.

The Lucerne Toolbox 2 to optimise axillary management for early breast cancer: a multidisciplinary expert consensus.

Kaidar-Person O, Pfob A, Gentilini O, Borisch B, Bosch A, Cardoso M EClinicalMedicine. 2023; 61:102085.

PMID: 37528842 PMC: 10388578. DOI: 10.1016/j.eclinm.2023.102085.

The accuracy of ultrasound-guided fine-needle aspiration and core needle biopsy in diagnosing axillary lymph nodes in women with breast cancer: a systematic review and meta-analysis.

Zheng H, Zhao R, Wang W, Liu X, Wang X, Wen C Front Oncol. 2023; 13:1166035.

PMID: 37416528 PMC: 10320388. DOI: 10.3389/fonc.2023.1166035.

Noninvasive prediction of axillary lymph node breast cancer metastasis using morphometric analysis of nodal tumor microvessels in a contrast-free ultrasound approach.

Ferroni G, Sabeti S, Abdus-Shakur T, Scalise L, Carter J, Fazzio R Breast Cancer Res. 2023; 25(1):65.

PMID: 37296471 PMC: 10257266. DOI: 10.1186/s13058-023-01670-z.

References

Voogd A, Coebergh J, van Driel O, Roumen R, van Beek M, Vreugdenhil A . The risk of nodal metastases in breast cancer patients with clinically negative lymph nodes: a population-based analysis. Breast Cancer Res Treat. 2000; 62(1):63-9. DOI: 10.1023/a:1006447825160. View

Giuliano A, Hunt K, Ballman K, Beitsch P, Whitworth P, Blumencranz P . Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011; 305(6):569-75. PMC: 5389857. DOI: 10.1001/jama.2011.90. View

Kald B, Boiesen P, Ronnow K, Jonsson P, Bisgaard T . Preoperative assessment of small tumours in women with breast cancer. Scand J Surg. 2005; 94(1):15-20. DOI: 10.1177/145749690509400105. View

Pain J, Ebbs S, Hern R, Lowe S, Bradbeer J . Assessment of breast cancer size: a comparison of methods. Eur J Surg Oncol. 1992; 18(1):44-8. View

Sclafani L, Baron R . Sentinel lymph node biopsy and axillary dissection: added morbidity of the arm, shoulder and chest wall after mastectomy and reconstruction. Cancer J. 2008; 14(4):216-22. DOI: 10.1097/PPO.0b013e31817fbe5e. View

Lanng C, Hoffmann J, Galatius H, Engel U . Assessment of clinical palpation of the axilla as a criterion for performing the sentinel node procedure in breast cancer. Eur J Surg Oncol. 2006; 33(3):281-4. DOI: 10.1016/j.ejso.2006.09.032. View

Docquier P, Paul L, Cartiaux O, Lecouvet F, Dufrane D, Delloye C . Formalin fixation could interfere with the clinical assessment of the tumor-free margin in tumor surgery: magnetic resonance imaging-based study. Oncology. 2010; 78(2):115-24. DOI: 10.1159/000306140. View

Heusinger K, Lohberg C, Lux M, Papadopoulos T, IMHOFF K, Schulz-Wendtland R . Assessment of breast cancer tumor size depends on method, histopathology and tumor size itself*. Breast Cancer Res Treat. 2005; 94(1):17-23. DOI: 10.1007/s10549-005-6653-x. View

Yeap B, Muniandy S, Lee S, Sabaratnam S, Singh M . Specimen shrinkage and its influence on margin assessment in breast cancer. Asian J Surg. 2007; 30(3):183-7. DOI: 10.1016/S1015-9584(08)60020-2. View

10.

Bosch A, Kessels A, Beets G, Rupa J, Koster D, van Engelshoven J . Preoperative estimation of the pathological breast tumour size by physical examination, mammography and ultrasound: a prospective study on 105 invasive tumours. Eur J Radiol. 2003; 48(3):285-92. DOI: 10.1016/s0720-048x(03)00081-0. View

11.

Barth A, CRAIG P, Silverstein M . Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Cancer. 1997; 79(10):1918-22. View

12.

Specht M, Fey J, Borgen P, Cody 3rd H . Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?. J Am Coll Surg. 2005; 200(1):10-4. DOI: 10.1016/j.jamcollsurg.2004.09.010. View

13.

Gann P, Colilla S, Gapstur S, Winchester D, WINCHESTER D . Factors associated with axillary lymph node metastasis from breast carcinoma: descriptive and predictive analyses. Cancer. 1999; 86(8):1511-9. DOI: 10.1002/(sici)1097-0142(19991015)86:8<1511::aid-cncr18>3.0.co;2-d. View

14.

Bachleitner-Hofmann T, Gnant M . [Surgical axilla dissection. Technical standard or obsolete method?]. Zentralbl Chir. 2000; 125(10):822-9. DOI: 10.1055/s-2000-10053. View

15.

Mullenix P, Carter P, Martin M, Steele S, Scott C, Walts M . Predictive value of intraoperative touch preparation analysis of sentinel lymph nodes for axillary metastasis in breast cancer. Am J Surg. 2003; 185(5):420-4. DOI: 10.1016/s0002-9610(03)00041-2. View

16.

Shoma A, Moutamed A, Ameen M, Abdelwahab A . Ultrasound for accurate measurement of invasive breast cancer tumor size. Breast J. 2006; 12(3):252-6. DOI: 10.1111/j.1075-122X.2006.00249.x. View

17.

Carmon M, Olsha O, Rivkin L, Spira R, Golomb E . Intraoperative palpation for clinically suspicious axillary sentinel lymph nodes reduces the false-negative rate of sentinel lymph node biopsy in breast cancer. Breast J. 2006; 12(3):199-201. DOI: 10.1111/j.1075-122X.2006.00241.x. View

18.

Hieken T, Harrison J, Herreros J, Velasco J . Correlating sonography, mammography, and pathology in the assessment of breast cancer size. Am J Surg. 2001; 182(4):351-4. DOI: 10.1016/s0002-9610(01)00726-7. View

19.

Schwab F, Burger H, Isenschmid M, Kuhn A, Mueller M, Gunthert A . Suspicious axillary lymph nodes in patients with unremarkable imaging of the breast. Eur J Obstet Gynecol Reprod Biol. 2010; 150(1):88-91. DOI: 10.1016/j.ejogrb.2010.02.011. View